Cancer Genomics Consortium — 2013 IRS Filing

EIN: 273232063 · Tax Year 2013 · Source: IRS Form 990

$197KTotal Revenue
$151KTotal Expenses
$163KNet Assets

Financial Summary

MetricAmount
Total Revenue$197K
Total Expenses$151K
Net Income$46K
Total Assets (End of Year)$163K

Frequently Asked Questions

What was Cancer Genomics Consortium's revenue in 2013?

Cancer Genomics Consortium reported $197K in total revenue for the 2013 tax year, with $151K in total expenses and $163K in net assets.

How did Cancer Genomics Consortium spend its money in 2013?

Detailed spending breakdown data is not available for Cancer Genomics Consortium's 2013 filing.

Where does this 2013 filing data come from?

This data comes from Cancer Genomics Consortium's IRS Form 990 filed for the 2013 tax year. Form 990 is a public document that all tax-exempt organizations must file annually with the IRS.

Understanding IRS Form 990

The IRS Form 990 is a public document that tax-exempt organizations must file annually. It provides detailed information about an organization's finances, governance, and activities. Key sections include revenue and expenses, compensation of officers, and program accomplishments.

All data shown on this page comes directly from Cancer Genomics Consortium's publicly available IRS Form 990 for the 2013 tax year. This information is provided for transparency and research purposes.

Other Filing Years

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014

Related Pages